Parabon NanoLabs Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$24.9M
- Investors
-
6
Parabon NanoLabs General Information
Description
Developer of a healthcare technology platform intended to offer a new class of nanopharmaceuticals. The company's platform offers a new class of nanopharmaceuticals and advanced forensic tools by fully leveraging the power of DNA, enabling clients to generate next-generation therapeutics and forensics.
Contact Information
Website
www.parabon-nanolabs.comCorporate Office
- 11260 Roger Bacon Drive
- Suite 406
- Reston, VA 20190
- United States
Corporate Office
- 11260 Roger Bacon Drive
- Suite 406
- Reston, VA 20190
- United States
Parabon NanoLabs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 01-Feb-2023 | $24.9M | Completed | |||
| 9. Grant | 17-Jun-2019 | Completed | ||||
| 8. Grant | 01-Jun-2021 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 01-Mar-2021 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 3. Grant | 30-Sep-2018 | Completed | ||||
| 2. Grant | 29-May-2013 | $50K | Completed | Generating Revenue | ||
| 1. Early Stage VC | 06-Jul-2010 | Completed | Startup |
Parabon NanoLabs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Parabon NanoLabs Patents
Parabon NanoLabs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2835109-A1 | Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals | Inactive | 04-May-2011 | ||
| US-20150320883-A1 | Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals | Active | 04-May-2011 | ||
| US-9579396-B2 | Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals | Active | 04-May-2011 | A61K38/164 |
Parabon NanoLabs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Parabon NanoLabs Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Defense Threat Reduction Agency | Government | |||
| DHS Science and Technology Directorate | Government | |||
| United States Department of Defense | Government | |||
| U.S. Department of Health and Human Services | Government | |||
| U. S. National Science Foundation | Government |
Parabon NanoLabs FAQs
-
When was Parabon NanoLabs founded?
Parabon NanoLabs was founded in 2008.
-
Where is Parabon NanoLabs headquartered?
Parabon NanoLabs is headquartered in Reston, VA.
-
What is the size of Parabon NanoLabs?
Parabon NanoLabs has 17 total employees.
-
What industry is Parabon NanoLabs in?
Parabon NanoLabs’s primary industry is Drug Discovery.
-
Is Parabon NanoLabs a private or public company?
Parabon NanoLabs is a Private company.
-
What is Parabon NanoLabs’s current revenue?
The current revenue for Parabon NanoLabs is .
-
Who are Parabon NanoLabs’s investors?
Defense Threat Reduction Agency, DHS Science and Technology Directorate, United States Department of Defense, U.S. Department of Health and Human Services, and U. S. National Science Foundation are 5 of 6 investors who have invested in Parabon NanoLabs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
